CD38 and neoplasm: NK cells treated with 8-Br-ADPR, an ADPR antagonist, as well as NK cells from Cd38−/− mice showed reduced tumor-induced granule polarization, degranulation, granzyme B secretion, and cytotoxicity of NK cells.